Apriem Advisors Johnson & Johnson Transaction History

Apriem Advisors

$793 Million
Q1 2024

A detailed history of Apriem Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, Apriem Advisors holds 22,296 shares of JNJ stock, worth $3.26 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

22,296

Previous 23,332 4.44%

Holding current value

$3.26 Million

Previous $3.66 Million 3.55%

% of portfolio

0.45%

Previous 0.49%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $160,807 - $168,598	-1,036 Reduced 4.44%	22,296 $3.53 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $145,454 - $158,721	-999 Reduced 4.11%	23,332 $3.66 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $114,787 - $128,591	-737 Reduced 2.94%	24,331 $3.79 Million
Q2 2023 Aug 08, 2023	SELL	$154.35 - $166.11 $41,828 - $45,015	-271 Reduced 1.07%	25,068 $4.15 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $19,485 - $23,253	129 Added 0.51%	25,339 $3.93 Million

Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $10,733 - $12,045	-67 Reduced 0.27%	25,210 $4.45 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $153,424 - $170,723	-951 Reduced 3.63%	25,277 $4.13 Million
Q2 2022 Aug 08, 2022	SELL	$168.19 - $186.01 $79,553 - $87,982	-473 Reduced 1.77%	26,228 $4.66 Million
Q1 2022 May 10, 2022	SELL	$158.14 - $179.59 $750,058 - $851,795	-4,743 Reduced 15.08%	26,701 $4.73 Million
Q4 2021 Feb 09, 2022	SELL	$155.93 - $173.01 $2.51 Million - $2.79 Million	-16,114 Reduced 33.88%	31,444 $5.38 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $293,284 - $325,917	-1,816 Reduced 3.68%	47,558 $7.68 Million
Q2 2021 Aug 10, 2021	SELL	$159.48 - $171.07 $555,947 - $596,350	-3,486 Reduced 6.59%	49,374 $8.13 Million
Q1 2021 May 10, 2021	SELL	$153.07 - $170.48 $3.6 Million - $4.01 Million	-23,521 Reduced 30.79%	52,860 $8.69 Million
Q4 2020 Feb 04, 2021	SELL	$137.11 - $157.38 $1.43 Million - $1.64 Million	-10,432 Reduced 12.02%	76,381 $12 Million
Q3 2020 Nov 10, 2020	SELL	$140.38 - $153.83 $225,029 - $246,589	-1,603 Reduced 1.81%	86,813 $12.9 Million
Q2 2020 Aug 07, 2020	SELL	$128.81 - $155.51 $168,354 - $203,251	-1,307 Reduced 1.46%	88,416 $12.4 Million
Q1 2020 May 07, 2020	SELL	$111.14 - $153.99 $250,287 - $346,785	-2,252 Reduced 2.45%	89,723 $11.8 Million
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $1.15 Million - $1.33 Million	9,056 Added 10.92%	91,975 $13.4 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $10.2 Million - $11.5 Million	80,640 Added 3538.39%	82,919 $10.7 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $56,132 - $61,734	-428 Reduced 15.81%	2,279 $317,000
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $73,420 - $81,637	-584 Reduced 17.75%	2,707 $378,000
Q4 2018 Feb 19, 2019	BUY	$122.84 - $147.84 $24,076 - $28,976	196 Added 6.33%	3,291 $425,000
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $49,726 - $58,437	409 Added 15.23%	3,095 $428,000
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $28,297 - $31,227	237 Added 9.68%	2,686 $326,000
Q1 2018 May 11, 2018	SELL	$125.1 - $148.14 $20,641 - $24,443	-165 Reduced 6.31%	2,449 $314,000
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $26,244 - $28,724	-200 Reduced 7.11%	2,614 $365,000
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $364,328 - $380,959	2,814	2,814 $366,000

Others Institutions Holding JNJ

# of Institutions

4,145

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apriem Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Apriem Advisors with notifications on news.

Account